Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - zopiclone, quantity: 7.5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; purified talc; povidone; maize starch; sodium starch glycollate type a; hypromellose; lactose monohydrate; titanium dioxide; calcium hydrogen phosphate dihydrate; macrogol 6000 - short term treatment of insomnia (7 to 14 days)

New Zealand - English - Medsafe (Medicines Safety Authority)

ipca pharma (nz) pty limited - propranolol hydrochloride 10mg - tablet - 10 mg - active: propranolol hydrochloride 10mg excipient: sunset yellow aluminium lake cl15985 lactose monohydrate magnesium stearate maize starch povidone quinoline yellow sodium starch glycolate - management of angina pectoris.

New Zealand - English - Medsafe (Medicines Safety Authority)

ipca pharma (nz) pty limited - propranolol hydrochloride 40mg - tablet - 40 mg - active: propranolol hydrochloride 40mg excipient: sunset yellow fcf aluminium lake cl15985 brilliant blue fcf aluminium lake cl42090 lactose monohydrate magnesium stearate maize starch povidone quinoline yellow sodium starch glycolate - management of angina pectoris.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, film coated - excipient ingredients: maize starch; povidone; colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; propylene glycol; macrogol 6000; purified talc; sodium starch glycollate type a - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, children from 10 years of age and adolescents, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. for adult patients, metformin may be used as initial treatment or in sulfonylurea failures either alone or in combination with a sulfonylurea and other oral agents or as adjuvant therapy in insulin requiring type 2 diabetes.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, film coated - excipient ingredients: maize starch; povidone; colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; propylene glycol; macrogol 6000; purified talc; sodium starch glycollate type a - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, children from 10 years of age and adolescents, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. for adult patients, metformin may be used as initial treatment or in sulfonylurea failures either alone or in combination with a sulfonylurea and other oral agents or as adjuvant therapy in insulin requiring type 2 diabetes.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metformin hydrochloride, quantity: 850 mg - tablet, film coated - excipient ingredients: maize starch; povidone; colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; propylene glycol; macrogol 6000; purified talc; sodium starch glycollate type a - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, children from 10 years of age and adolescents, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. for adult patients, metformin may be used as initial treatment or in sulfonylurea failures either alone or in combination with a sulfonylurea and other oral agents or as adjuvant therapy in insulin requiring type 2 diabetes.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metformin hydrochloride, quantity: 850 mg - tablet, film coated - excipient ingredients: maize starch; povidone; colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; propylene glycol; macrogol 6000; purified talc; sodium starch glycollate type a - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, children from 10 years of age and adolescents, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. for adult patients, metformin may be used as initial treatment or in sulfonylurea failures either alone or in combination with a sulfonylurea and other oral agents or as adjuvant therapy in insulin requiring type 2 diabetes.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, film coated - excipient ingredients: maize starch; povidone; colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; propylene glycol; macrogol 6000; purified talc; sodium starch glycollate type a - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, children from 10 years of age and adolescents, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. for adult patients, metformin may be used as initial treatment or in sulfonylurea failures either alone or in combination with a sulfonylurea and other oral agents or as adjuvant therapy in insulin requiring type 2 diabetes.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, film coated - excipient ingredients: maize starch; povidone; colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; propylene glycol; macrogol 6000; purified talc; sodium starch glycollate type a - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, children from 10 years of age and adolescents, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. for adult patients, metformin may be used as initial treatment or in sulfonylurea failures either alone or in combination with a sulfonylurea and other oral agents or as adjuvant therapy in insulin requiring type 2 diabetes.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sipcam pacific australia pty. limited - ametryn - suspension concentrate - ametryn triazine active 500.0 g/l - herbicide - fallow crop land weed control | firebreak weed control | footpath | headland weed control | industrial land or area | pineapple - african star grass | awnless barnyard grass | barnyard or water grass | bathurst burr | bellvine | billygoat weed or blue top | californian burr | caltrop or yellow vine | chinese burr | cobbler's pegs | couch grass | crowsfoot grass | flannel weed - abutilon oxycarpum | fleabane | gambia pea | general weed - see label | grass weeds - see label | green summer grass | guinea grass | lovegrass | mossman river or burr grass | noogoora burr | paspalum | plantain | pretty boy or painted spurge | rattlepod | rhodes grass | sedge or annual sedge | sida | star of bethlehem or cupid's flower | stinking roger | summer or crab grass | thickhead | tridax daisy | abyssinian rhodes grass | annual lovegrass | annual summer grass | barnyard grass | bindy-eye | blady grass | brome grass | buffalo grass | bullhead | bull's head | burr bush | caltrop burr | cathead | cat's-head | cockleburr | common plantain | conyza spp. | couch grass | crab grass | cyperus spp. | dandelion | flatweed | goat's-head | green couch | green summer